Efficacy and safety of a basal insulin + 2‐3 oral antihyperglycaemic drugs regimen versus a twice‐daily premixed insulin + metformin regimen after short‐term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open‐label, randomized controlled BEYOND‐V trial

AIM: To compare the efficacy and safety of basal insulin glargine 100 units/ml (Gla) + 2‐3 oral antihyperglycaemic drugs (OADs) with twice‐daily premixed insulin aspart 70/30 (Asp30) + metformin (MET) after short‐term intensive insulin therapy in adults with type 2 diabetes in China. MATERIALS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qi, Li, Yijun, Wan, Hailong, Wang, Junfen, Xu, Binhua, Wang, Guoping, Jiang, Chengxia, Liang, Li, Feng, Wei, Liu, Jingcheng, Wang, Ting, Zhang, Xia, Cui, Nan, Mu, Yiming, Guo, Lixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543477/
https://www.ncbi.nlm.nih.gov/pubmed/35642463
http://dx.doi.org/10.1111/dom.14780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543477/
https://www.ncbi.nlm.nih.gov/pubmed/35642463
http://dx.doi.org/10.1111/dom.14780

Ejemplares similares